Na Rong, Helfand Brian T, Chen Haitao, Conran Carly A, Crawford Susan E, Hayward Simon W, Tammela Teuvo L J, Hoffman-Bolton Judy, Zheng Siqun L, Walsh Patrick C, Schleutker Johanna, Platz Elizabeth A, Isaacs William B, Xu Jianfeng
Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois.
Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Prostate. 2017 Aug;77(11):1213-1220. doi: 10.1002/pros.23380. Epub 2017 Jun 28.
Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) are common conditions. Little is known about their etiologies except that studies have suggested a substantial heritable component. Our objective is to provide a comprehensive, genome-wide evaluation of inherited risks and possible mechanisms of etiology in BPH.
We performed a three-stage, genome-wide association study (GWAS) of men from three independent populations, the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial, the CLUE II cohort, and a Finnish hospital-based population. DNA samples were genotyped using the Illumina HumanOmniExpress BeadChip in REDUCE and CLUE II, and using the Sequenom iPLEX system for the confirmation stage in the Finnish population. A logistic regression model was used to evaluate the association between each SNP and BPH/LUTS.
Fourteen SNPs reached P < 5.0 × 10 in the meta-analysis of the two GWASs (CLUE II and REDUCE). A total of 773 SNPs were chosen for the confirmation step in the Finish cohort. Only one SNP (rs17144046) located ∼489 kb downstream of GATA3 remained significant after correction for multiple testing (P < 6.5 × 10 ). This SNP marginally reached the GWAS significance level after performing a meta-analysis of the three stages (P = 8.89 × 10 ). Expression quantitative trait loci (eQTL) analyses showed that the risk allele (G) of rs17144046 was significantly associated with increased expression of GATA3 (P = 0.017). Reported studies indicated a close correlation between GATA3 and BPH pathogenesis and progression.
Rs17144046 located near GATA3 was significantly associated with BPH/LUTS in three independent populations, but did not reach a stringent GWAS significance level. Genetic variants of GATA3 may play a role in the inherited susceptibility and etiology of BPH/LUTS. Further research in this area is needed.
良性前列腺增生(BPH)及相关下尿路症状(LUTS)是常见病症。除了研究表明存在显著的遗传因素外,对其病因知之甚少。我们的目标是对BPH的遗传风险和可能的病因机制进行全面的全基因组评估。
我们对来自三个独立人群的男性进行了三阶段全基因组关联研究(GWAS),这三个独立人群分别是度他雄胺降低前列腺癌事件(REDUCE)试验、CLUE II队列以及芬兰一个基于医院的人群。在REDUCE和CLUE II中,使用Illumina HumanOmniExpress BeadChip对DNA样本进行基因分型,在芬兰人群的验证阶段使用Sequenom iPLEX系统。使用逻辑回归模型评估每个单核苷酸多态性(SNP)与BPH/LUTS之间的关联。
在两项GWAS(CLUE II和REDUCE)的荟萃分析中,14个SNP达到P < 5.0×10。总共选择了773个SNP在芬兰队列中进行验证步骤。经过多重检验校正后,只有一个位于GATA3下游约489 kb处的SNP(rs17144046)仍然显著(P < 6.5×10)。在对三个阶段进行荟萃分析后,这个SNP勉强达到GWAS显著性水平(P = 8.89×10)。表达数量性状基因座(eQTL)分析表明,rs17144046的风险等位基因(G)与GATA3表达增加显著相关(P = 0.017)。已发表的研究表明GATA3与BPH发病机制和进展密切相关。
位于GATA3附近的rs17144046在三个独立人群中与BPH/LUTS显著相关,但未达到严格的GWAS显著性水平。GATA3的基因变异可能在BPH/LUTS的遗传易感性和病因中起作用。该领域需要进一步研究。